Y-Biologics, Inc. (338840.KQ) stock: key figures, P/E, revenue and dividend
Health Care · South Korea
Y-Biologics, Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 5.76 bn KRW | 2.91 bn KRW |
| Gross profit | 4.37 bn KRW | 2.38 bn KRW |
| Operating income | -7.12 bn KRW | -9.27 bn KRW |
| EBIT | -6.40 bn KRW | -40.77 bn KRW |
| Net income | -6.44 bn KRW | -42.02 bn KRW |
| Diluted EPS – continuing operations | -435.76 KRW | -2,768.77 KRW |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Y-Biologics, Inc.
Y-Biologics, Inc., an antibody therapeutics development company, engages in the research and development of immuno-oncology drugs and antibody drugs. The company develops YBL-006, a PD-1 immune-oncology agent that is phase 1 clinical stage for the treatment of solid tumor. It also develops immunoregulatory monoclonal antibodies, such as YBL-011 and AR062 for the treatment of solid cancers; AR166, AR169, and AR170 for solid cancers; and AR153, a pH-dependent antibody for the treatment of solid cancer. Y-Biologics, Inc. was incorporated in 2007 and is headquartered in Daejeon, South Korea.
More stocks
- Sun Silver Ltd (SS1.AX)
- JW Shinyak Corporation (067290.KQ)
- Topower Co Ltd (3226.TWO)
- Cairo Mezz PLC (CAIROMEZ.AT)
- Keyang Electric Machinery Co Ltd (012205.KS)
- Foncière Vindi Société Anonyme (MLVIN.PA)
- Flexopack Société Anonyme Commercial and Industrial Plastics Company (FLEXO.AT)
- BCM Resources Corp (B.V)
- PT Indonesia Kendaraan Terminal Tbk (IPCC.JK)
- WeLeader Biomedical Co., Ltd. (7713.TWO)
- XL Holdings Bhd (7121.KL)
- Shutterstock, Inc. (SSTK)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.